Residential College | false |
Status | 已發表Published |
Profiling patent compounds in lipid nanoparticle formulations of siRNA | |
Han, Yunfeng1; Wang, Mengyang1; Chen, Yu1; Ouyang, Defang1,2,3; Zheng, Ying1,4; Hu, Yuanjia1,2,3 | |
2024-12-10 | |
Source Publication | Molecular Therapy Nucleic Acids |
ISSN | 2162-2531 |
Volume | 35Issue:4Pages:102362 |
Abstract | Lipid nanoparticles (LNPs) have emerged as a prominent delivery system for nucleic acid drugs, attracting significant attention, especially through the successful development of several commercial products. As a key component in LNPs, cationic lipids have long served as a key technical barrier to block competitors by building up a complex patent thicket. However, there have been few studies as yet that have comprehensively analyzed the patented compounds in LNP formulations, despite a large number of technical reviews and original articles. In this context, this study focuses on analyzing the macroscopic landscapes and microscopic molecular characteristics of LNP patents, aiming to provide a valuable reference for researchers and developers in making informed technological and commercial decisions. By mining 2,994 patents, 265 formulas, 7,674 compounds, and 28,789 fragments, this work sketches the empirical golden ratio of lipid materials in LNP formulation, discloses the advanced technology in the formulation, characterizes high-frequency fragments of heads, linkers and tails in both novel cationic lipids as well as targeting lipids, and establishes a virtual focus library of LNP materials. |
DOI | 10.1016/j.omtn.2024.102362 |
URL | View the original |
Indexed By | SCIE |
Language | 英語English |
WOS Research Area | Research & Experimental Medicine |
WOS Subject | Medicine, Research & Experimental |
WOS ID | WOS:001350523400001 |
Publisher | CELL PRESS, 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 |
Scopus ID | 2-s2.0-85207771552 |
Fulltext Access | |
Citation statistics | |
Document Type | Journal article |
Collection | DEPARTMENT OF PHARMACEUTICAL SCIENCES Institute of Chinese Medical Sciences THE STATE KEY LABORATORY OF QUALITY RESEARCH IN CHINESE MEDICINE (UNIVERSITY OF MACAU) |
Corresponding Author | Zheng, Ying; Hu, Yuanjia |
Affiliation | 1.State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China 2.Centre for Pharmaceutical Regulatory Sciences, University of Macau, Macao SAR, China 3.DPM, Faculty of Health Sciences, University of Macau, Macao SAR, China 4.DPS, Faculty of Health Sciences, University of Macau, Macao SAR, China |
First Author Affilication | Institute of Chinese Medical Sciences |
Corresponding Author Affilication | Institute of Chinese Medical Sciences; Faculty of Health Sciences; University of Macau |
Recommended Citation GB/T 7714 | Han, Yunfeng,Wang, Mengyang,Chen, Yu,et al. Profiling patent compounds in lipid nanoparticle formulations of siRNA[J]. Molecular Therapy Nucleic Acids, 2024, 35(4), 102362. |
APA | Han, Yunfeng., Wang, Mengyang., Chen, Yu., Ouyang, Defang., Zheng, Ying., & Hu, Yuanjia (2024). Profiling patent compounds in lipid nanoparticle formulations of siRNA. Molecular Therapy Nucleic Acids, 35(4), 102362. |
MLA | Han, Yunfeng,et al."Profiling patent compounds in lipid nanoparticle formulations of siRNA".Molecular Therapy Nucleic Acids 35.4(2024):102362. |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment